A Study of C-CAR039 (Prizloncabtagene Autoleucel) in Patients With Relapsed/Refractory Large B-Cell Lymphoma
Clinical trial NCT05800977 · RECRUITING
Trial details
- NCT number
- NCT05800977
- Sponsor
- Shanghai AbelZeta Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-22
- Primary completion
- 2027-03-31
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.